I AM PAUL AUCTION sIMPSON OF EAB INC, A PROFESSIONAL EVALUATION COMPANY WORKING[DRAFT - ATTORNEY CLIENT COMMUNICATION-ATTORNEY WORK
Case File
efta-efta00726981DOJ Data Set 9OtherJeffrey Epstein
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00726981
Pages
10
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Jeffrey Epstein
April 16, 2010
JPMORGAN PRIVATE BANK CASH MANAGEMENT
Global Investment Specialist
Jeff Matusow
Investment products: Not FDIC insured • No bank guarantee • May lose value
Please see important information at the end of this presentation.
J.P. Morgan
EFTA00726981
Option 1 - Day-to-Day
Liquidity
Money Market Strategy:
Managing Short Term
Liquidity Needs
r
Objective:
- Meet near term liquidity needs
- Mitigate principal volatility in a rising
rate environment
Solution:
- J.P. Morgan Capital Prime Money
Market Fund (CJPXX)
•
Money Market Fund
•
Daily Liquidity
•
2a7 regulated
• Weighted Average Maturity:
51 days
•
Yield : 0.11%
Option 2- Reserve Cash
Managed Cash Strategy:
Enhancing your Cash Yield
r
-Wr
Objective:
— Enhance income by investing in short
term high quality securities with an
average duration slightly longer than
money market funds
— Minimize principal volatility to a
level appropriate for a 6-18 month
time horizon
Solution:
- J.P. Morgan Taxable Managed
Cash Strategy
•
Separately Managed Account
•
T+3 liquidity
•
Duration: 0.5 years / 0.9 years
•
Average Life: 0.7 years / 1 year
•
Yield: 0.6% / 0.8%
Option 3 - Strategic Cash
Short Term Fixed Income Strategy:
Augmenting your Total Return
r
Objective:
— Complements cash portfolio seeking
to enhance total returns
— Short term fixed income investment
intended for strategic cash with a
time horizon of at least 18 months
Solution:
- J.P. Morgan Short Duration Bond
Fund (JSDUX)
•
Short term fixed income
mutual fund
• T+1 liquidity
• Duration: 1.9 years
•
Average Life: 2.3 years
•
Yield: 1.27%
J.P. Morgan
Neither JPIVIorgan nor any of its affiliates offer tax or legal advice. Such advice should be obtained from your professional
tax and legal advisors. The views and strategies described herein may not be suitable for all investors. This information is
not intended as an offer or solicitation for the purchase or sale of any financial instrument and is being provided merely to
illustrate a particular investment strategy. Past performance is not a guarantee of comparable future results.
EFTA00726982
Day-to-Day Liquidity: J.P. Morgan USD Prime Money Market Fund Profile (CPXX)
As of April 15, 2010
Fund Features
Current yield (7 day avg.)1
WAM
Assets
Credit Rating
Minimum investment (Capital)
Settlement
Annual Total Expenses
CUSIP
Ticker
0.11%
51 days
$146.3 bn
AAAm, Aaa/MR1+, AAAN1+
(S&P, Moody's, Fitch)
$50 mm
T+0 (5:00 PM EST cutoff time)
18 bps
4812A0367
CJPXX
'Source: JPMorgan Asset Management as of April 15, 2010
Investment Parameters
• Invested in low risk money market instruments
• Minimum credit quality of A-1/P-1
• Minimum 50% assets A-1+/P-1
• Diversified pool of investments
• Maximum 5% in single issuer (ex repo)
• Maximum security maturity 397 days
• Maximum portfolio maturity 60 days
Maturity Distribution
50%
43.9%
45%
41.3%
40%
35%
30%
25%
20%
15%
13.3%
10%
5%
1.5%
0%
Less than 1
1- 3 Months
3- 6 Months
6- 9 Months
Month
Portfolio Composition
USGovernment Repos
Agencies
0.9%
4.6%
Trite Deposes
12.3%
Commercial Paper
27.3%
Corporate Bonds
0.3%
Certificates of
Deposit
54.6%
Due to rounding, values may not total 100%.
'For floating rate securities the maturity is defined as the time to next reset. For amortizing securities the maturity is defined as the
average life of the bond.
J. P Morgan
Past performance Is not Indicative of future results. Investment returns will fluctuate so that the redemption amount may be
worth more or less than the original investment. Performance information is shown net of investment management fees.
Performance includes the reinvestment of interests when applicable. Please refer to the prospectus for more detailed information.
2
EFTA00726983
J.P. Morgan
Reserve Cash - Option 1: J.P. Morgan Taxable Managed Cash Strategy
As of April 15, 2010
Portfolio Summary
Average Credit Quality
AA
Average Duration
0.5 Years
Average Life
0.7 Years
Average Market Yield
0.6%
Typical Benchmarks
•
Federal Funds Effective
•
iMoneyNet First Tier Instil
•
Lipper Money Market Fund Inch
•
30-Day Commercial Paper
•
3-Month Certificates of Deposit
•
3-Month U.S. Treasury Bills
•
6-Month U.S. Treasury Bills
•
Ibbotson U.S. Treasury Bills
•
Consumer Price Index (CPIU)
Portfolio Duration vs. Average Life Breakdown
0 - 1 years
1 - 2 years
• Duration
• Average Life
0%
10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Portfolio Sector Breakdown
FDIC-TLGP
3%
Commercial
Paper &
Certificates of
Deposit
17%
Non Mortgage
ABS
21%
US Tbills
2%
Agency
7%
Sovereigns/
Supras
2%
Corporate
Bonds
48%
Portfolio Credit Breakdown
AAA
33%
A
37%
Average Credit Quality: AA
Neither JPMorgan Chase & Co. nor any of its affiliates offer tax or legal advice. Such advice should be obtained from your professional tax and legal advisors.
Note: Market value and market yield reflected may be subject to change due to interest rate fluctuations and changes in credit and market
liquidity conditions. Market prices and values reflected may differ from liquidation values. Average Life represents the weighted average
period of principal paybacks and may vary for securities with principal prepayment variability. Legal Final Maturity may be longer than
average life. Duration represents the sensitivity of a fixed income portfolio market value to interest rate fluctuations. Private placement
securities are internally rated by the J.P. Morgan Investment Management Credit Team. Portfolio characteristics will vary over time based on
market conditions. This report snot intended as an offer or solicitation for the purchase or sale of any portfolio. The investment strategy
referenced herein may not be suitable for all investors.
3
EFTA00726984
J.P. Morgan
Reserve Cash - Option 2: J.P. Morgan Taxable Managed Cash Strategy
As of April 15, 2010
Portfolio Summary
Average Credit Quality
AA
Average Duration
0.9 Years
Average Life
1.0 Years
Average Market Yield
0.8%
Typical Benchmarks
•
Federal Funds Effective
•
iMoneyNet First Tier Instil
•
Lipper Money Market Fund Inch
•
30-Day Commercial Paper
•
3-Month Certificates of Deposit
•
3-Month U.S. Treasury Bills
•
6-Month U.S. Treasury Bills
•
Ibbotson U.S. Treasury Bills
•
Consumer Price Index (CPIU)
Portfolio Duration vs. Average Life Breakdown
0 - 1 years
1 - 2 years
• Duration
• Average Life
0%
10%
20%
30%
40%
50%
60%
70%
80%
Portfolio Sector Breakdown
Agency
6%
US Short Term
Treasuries
US Tbills 5%
3%
FDIC-TLGP
2%
Commercial
Paper &
Certificates of
Deposit
12%
Non Mortgage
ABS
22%
Agency
Discount
Notes
5%
Sovereigns/
Supras
3%
Corporate
Bonds
42%
Portfolio Credit Breakdown
A
AAA
46%
AA
13%
A1/P1
Average Credit Quality: AA 12%
Neither JPMorgan Chase & Co. nor any of its affiliates offer tax or legal advice. Such advice should be obtained from your professional tax and legal advisors.
Note: Market value and market yield reflected may be subject to change due to interest rate fluctuations and changes in credit and market
liquidity conditions. Market prices and values reflected may differ from liquidation values. Average Life represents the weighted average
period of principal paybacks and may vary for securities with principal prepayment variability. Legal Final Maturity may be longer than
average life. Duration represents the sensitivity of a fixed income portfolio market value to interest rate fluctuations. Private placement
securities are internally rated by the J.P. Morgan Investment Management Credit Team. Portfolio characteristics will vary over time based on
market conditions. This report 'knot intended as an offer or solicitation for the purchase or sale of any portfolio. The investment strategy
referenced herein may not be suitable for all investors.
4
EFTA00726985
Strategic Cash - J.P. Morgan Short Duration Bond Fund (JSDUX)
J.P. Morgan
EFTA00726986
NOT FDIC INSURED I NO BANK GUARANTEE I MAY LOSE VALUE
JPMorgan
Short Duration Bond Fund
Ultra (JSDUX)
Data as of March 31, 2010
Fund overview
Objective
The Fund seeks currem income consistent with preservation of
capital through investment in high- and medium-grade fixed
income securities.
Strategy/Investment process
• Under normal conditions. may invest at least 8016 in bonds.
• Generally maintains an average weighted maturity of 3 years
Total returns
or less. taking into account expected amortization and
Performance at NAY (96)
Latest QTR
YTD
prepayment of principal on certain investments.
Ultra'
0.91
0.91
• Seeks market sectors and individual securities that it believes
Barclays Capital 1.3 Year U.S. Govemment/Cred4
will perform well over time.
Bond Index
0.89
0.89
• May purchase taxable or tax-exempt municipal securities.
Lipper Short U.S. Government Finds Index
0.65
026
Average maturity/quality
SEC yields (%)
Ultra
Short
Int.
Long
30-Day SEC Yield
127
30-Day SEC Yield (Unsubsidized)
1.21
MEM
High
Calendar-year returns (%)
Ultra at NAY
2005
2.20
2006
4.57
Barclays Capital 1•3 Year U.S. Govemment/Cred rt
Medium
Bond Index
1.77
4.25
Lipper Shan U.S. Government Funds Index
1.68
4.02
Fund performance*
As it was designed to do. the share price of the iPMorgan
Short Duration Bond Fund has remained relatively stable
since the share class's inception in February 2005. Share
price is for Ultra. Past performance is no guarantee of future
results.
S20
sis
Ito
SS
SO
2495
Portfolio managers/industry experience
Gregg Hrivnak. 24 years
Richard Figuly. 16 years
Portfolio characteristics
Humber of holdings
1394
Fund assets (in billions)
$836
Portfolio breakdown (%)"
Asset Backed Securities
10.1
Collateralized Mortgage Obligations
11.4
Commercial Mortgage-Backed Securities
1.4
Corporate Bonds
13.0
Mortgage Pass-Through Securities
8.1
Short-Term Investments
4.3
U.S. Government Agency Securities
23.8
U.S. Treasury Obligations
27.5
Other
0.4
Average life PIO"
Less than one year
17.4
Years 1.3
53.3
Years 3.5
25.0
years 5.7
4.0
Years 7-10
0.3
Duration
1.87 yeas
Average Ife
2.33 yeas
Quality (%).•
US Government
65.4
AAA
20.7
AA
4.1
A
6.6
BBB
2.7
BB
0.3
B
0.1
"Due to rounding values may not total 100%.
Insight + Process = Results"
Ca
445
4 ,
Average annual total returns
1 yr
3 yrs
S yrs
00
39p
10 yrs
4.87
4.95
4.65
4.70
4.15
5.01
4.56
4.82
3.51
4.02
3.85
4.04
2007
6.33
648;
2008
3.88
4.97
2009
520
3.83
5.56
3.46
3.59
*The performance quoted is past performance and is not a guarantee of future result:. Mutual funds are subject to certain
market risks. Investment returns and principal value of an investment will fluctuate so that an investors shares. when
redeemed. maybe worth moreor less than original cost. Current performance may be higher or lower than the performance
data shown. for performance current to the most recent month.end please call 1-80048041a
Morningstar ratings
Overall
3-Year
5.Year
10-Year
Ratirg/number of funds in category
****/365
****/385
****1317
Not yet rated
Ultra share class: Short-Term Bond Category
Morningstar calculates a Morningstar Rating metric each month by subtracting the return on a 90-day US. Treasury Bill
from the fund's load-adjusted return for the same period, and then adjusting this excess return for rig.
Annual operating expenses
Ultra
Expense cap expiation date
6/30/2010
Expense cap (%)
0.44
Total annual Fund operating expenses (6)2
0.40
:7Ile Investment Advisor. Administrator and Distributor have contractually agr e e d to wan. e feesartd/or reimburse expenses to the
extent that Total Annual Operating Expenses (excluding Acquired Fund Fees andftoeoses, dividend expenses relating to short sales.
interest, taxes and extraordinary expenses and expenses related to the Board of trustees' deferred compensation olan)exceed the
expense cap of the average daily net assets through the expense cap expiration date. Withourthe Acquired fund fees and Expenses.
the tota(Annual Operating Expenses and fretExpenseswould have been loner. la addition. the Fund's service providers may
bolontat i 1 y waiv e or reimburse certain of their fees. as they may determine. from time to time.
Portfolio statistic
Ultra
Inception date
2)22/2005
Investment minimum
$5M
Fund number
3944
CUSIP
4812(0167
Please refer to the back of the page for important disclosure information
including risks associated with investing in the Fund.
J.P.Morgan
Asset Management
6
EFTA00726987
NOT FDIC INSURED I NO BANK GUARANTEE I MAY LOSE VALUE
JPMorgan Short Duration Bond Fund
Ultra (1SDUX)
Contact JPMorgan Distribution Services, Inc. at 1.800.480.4111 fora fund prospectus. You can also visit us at
wvacipmorganfurtds.com. Investors should carefully consider the investment objectives and risks as well as charges and expenses
of the mutual fund before investing. The prospectus contains this and other Information about the mutual fund. Read the
prospectus carefully before Investing.
RISKS ASSOCIATED WMIIIIIIEST1NG IN THE FUND:
Because this Fund primarily invests M bonds. it is subject to interest rate rnks. Bond prices generally fall when interest rates rise.
The Fund may invest in futures contracts and other derivatives. This may make the Fund more volatile. The portfolio characteristics (excluding sector and
holdings) include derivative positions.
RETURNS:
The quoted performance of the Fund includes performance of a predecessor fund/share class prior to the Fund's commencement of operations. Please
refer to the current prospectus for further information.
IIORNINGSTAR DISCLOSURE:
Morningstar cakulates a Morningstar Rating metric each month by subtracting the return on a 90.day US. Treasury Bill from the fund's load-
adjusted return for the same period. and then adjusting this excess return for risk. The top 10%04 funds in each broad asset class receive 5 stars.
the next 22.5% receive 4 stars. the next 35% receive 3 stars. the next 223% receive 2 stars and the bottom 10% receive 1 star. The Overall
Morningstar Rating for a fund is derived from a weighted average of the performance figures associated with its three-. five- and ten-year (if
applicable) Momingstar Rating metrics. Past performance is no guarantee of future results. Different share classes may have different ratings.
INDEXES DEFINED:
The Barclays Capital 1-3 Year U.S. Government/Credit Bond index is an unmanaged index of investment grade government and corporate bonds with
maturities of one to three years. The performance of the index does not reflect thededuction of expenses associatedwith a mutual fund. such as
investment management fees. By contrast the performance of the Fund reflects the deduction of the mutual fund expenses. including sales charges if
applicable. An irdividual cannot invest directly man index_
The Lipper Short U.S. Government Funds Index represents the total returns of the funds in the indicated category. as defined by Lipper. Inc. An individual
cannot invest directly n an index.
02010. American Bankers Association. CUSIP Database provided by the Standard & Poor's CUSIP Service Bureau. a division of The McGraw-Hill Companies.
Inc. All rights reserved.
Total return assumes reinvestment of dividends and capital gains distributions and reflects the deduction of any sales charges. where applicable.
Performance may reflect the waiver of a portion of the Fund's advisory or administrative fees for certain periods since the inception date. If fees had not
been waived performance would have been less favorable.
LP. Morgan Funds are distributed by WMorgan Distribution Services. Inc. which is an affiliate of II:Morgan Chase& Co. Affiliates of IP/Aorgan Chase & Co.
receive fees for providing various services to the funds. Products and services are offered by 1P1lorgan Distribution Services. Inc.. member Ft NRA/SIPC.
FS-SDB-U-0310
J.P.Morgan
Asset Management
7
EFTA00726988
Annual taxable fixed income management fee schedules for Separately Managed
investment management accounts'
The following Fixed Income Fee Schedule is charged on the total market value of the account2:
ACTIVE MANAGEMENT
Short Term Cash Management _> $20mm
0.25% on the first $20 million
0.20% on the next $80 million
0.15% on amount over $100 million
$25,000 minimum fee
1.
Brokerage fees and costs for executing securities transactions, legal fees and other out-of-pocket expenses incurred on behalf of the account will also be passed through to the
account at cost. There are no charges for trades in J.P. Morgan Funds. As described in the J.P. Morgan Funds Disclosure statement and the fund prospectuses, J.P. Morgan affiliates
are paid fees by the J.P. Morgan Funds for providing investment advisory, distribution, administrative, shareholder servicing and other services to the J.P. Morgan Funds. As
disclosed in the prospectuses, J.P. Morgan affiliates, at their own expense and out of their profits, may provide additional cash payments to financial intermediaries. Your advisor
can provide copies of mutual fund prospectuses describing such fees, as well as further information about the fees earned by or additional cash payments received by J.P. Morgan
affiliates. Prospectuses also are available by calling J.P. Morgan Distribution Services, Inc., at 800-480.4111, option 3 or www„Mmorganhinels r m. Investments in J.P. Morgan Funds
generally are made in Select or Institutional shares classes which have no sales load or 12b-1 fees. Please contact your advisor for additional information.
2.
The Fixed Income Fee Schedule is charged on the total market value of the account excluding JPMorgan Mutual Funds accrued income, sweeps, uninvested cash, and JPM corporate
bonds.
3.
Please contact your JPM representative for specific fees related to the asset allocation outlined in your Disaetionary Portfolio Mandate. Term sheets for individual investments are
available upon request.
J.P.Morgan
a
EFTA00726989
Important information
IRS Circular 230 Insclostawl.IP. Morgan Chase & Co. and its affiliates
do not provide tax advice. Accordingly, any discussion of U.S. tax
matters contained herein (including any attachments) is not intended
or written to be used, and cannot be used, in connection with the
promotion, marketing or recommendation by anyone unaffiliated with
I.P. Morgan Chase & Co. of any of the matters addressed herein or for
the purpose of avoiding U.S. tax-related penalties.
Each recipient of this presentation, and each agent thereof, may disclose to any
person, without limitation, the U.S. income and franchise tax treatment and tax
structure of the transactions described herein and may disclose all materials of
any kind (including opinions or other tax analyses) provided to each recipient
insofar as the materials relate to a U.S. income or franchise tax strategy
provided to such recipient by 1.P. Morgan Chase & Co. and its subsidiaries.
Bank products and services are offered by 1.P. Morgan Chase Bank, N.A. and its
affiliates. Securities products and services are offered by 1.P. Morgan Securities
Inc., member NYSE, FINRA and SIPC.
This material is not intended as an offer or solicitation for the purchase or sale
of any financial instrument. J.P. Morgan Securities Inc. or its brokerage affiliates
may hold a position or act as market maker in the financial instruments of any
issuer discussed herein or act as an underwriter, placement agent, advisor or
lender to such issuer. The views and strategies described herein may not be
suitable for all investors. The discussion of loans or other extensions of credit in
this material is for illustrative purposes only. No commitment to lend by 1.P.
Morgan should be construed or implied. This material is distributed with the
understanding that we are not rendering accounting, legal or tax advice. Estate
planning requires legal assistance. You should consult with your independent
advisors concerning such matters.
We believe the information contained in this material to be reliable but do not
warrant its accuracy or completeness. Opinions, estimates, and investment
strategies and views expressed in this document constitute our judgment based
on current market conditions and are subject to change without notice. This
material should not be regarded as research or a 1.P. Morgan research report.
Opinions expressed herein may differ from the opinions expressed by other
areas of 1.P. Morgan, including research. The investment strategies and views
stated here may differ from those expressed for other purposes or in other
contexts by other J.P. Morgan market strategists.
J.P. Morgan Securities Inc. may act as a market maker in markets relevant to
structured products or option products and may engage in hedging or other
operations in such markets relevant to its structured products or options exposures.
Structured products and options are not insured by the Federal Deposit Insurance
Corporation (FDIC), the Federal Reserve Board, or any other governmental agency.
In discussion of options and other strategies, results and risks are based solely on
hypothetical examples cited; actual results and risks will vary depending on specific
circumstances. Investors are urged to consider carefully whether option or option-
related products in general, as well as the products or strategies discussed herein
are suitable to their needs. In actual transactions, the client's counterparty for OTC
derivatives applications is 1.P. Morgan Chase Bank, N.A., London branch. For a copy
of the "Characteristic and Risks of Standardized Options" booklet, please contact
your 1.P. Morgan Advisor.
Real estate, hedge funds, and other private investments may not be suitable for all
individual investors, may present significant risks, and may be sold or redeemed at
more or less than the original amount invested. Private investments are offered
only by offering memoranda, which more fully describe the possible risks. There
are no assurances that the stated investment objectives of any investment product
will be met. Hedge funds (or funds of hedge funds): often engage in leveraging
and other speculative investment practices that may increase the risk of investment
loss; can be highly illiquid; are not required to provide periodic pricing or valuation
information to investors; may involve complex tax structures and delays in
distributing important tax information; are not subject to the same regulatory
requirements as mutual funds; and often charge high fees. Further, any number of
conflicts of interest may exist in the context of the management and/or operation
of any hedge fund.
J.P. Morgan Funds are distributed by J.P. Morgan Distribution Services, Inc., which is
an affiliate of 1.P. Morgan Chase & Co. Affiliates of J.P. Morgan Chase & Co. receive
fees for providing various services to the funds. Call J.P. Morgan Distribution
Services at 1.800480.4111 or visit www.jpmorganfunds.com for the prospectus.
Investors should carefully consider the investment objectives, risks, charges and
expenses of the mutual funds before investing. The prospectus contains this and
other information about the mutual fund and should be read carefully before
investing.
As applicable, portions of mutual fund performance information may be provided
by Upper, a Reuters company, subject to the following: O 2008 Reuters. All rights
reserved. Any copying, republication or redistribution of Upper content, including
by caching, framing or similar means, is expressly prohibited without the prior
written consent of Upper. Upper shall not be liable for any errors or delays in the
content, or for any actions taken in reliance thereon.
Past performance Is no guarantee of future results.
Additional information is available upon request.
O 20101.P. Morgan Chase & Co.
9
J.P.Morgan
EFTA00726990
Technical Artifacts (9)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
wvacipmorganfurtds.comDomain
www.jpmorganfunds.comFlight #
AA12Phone
1.800.480.4111Phone
1.800480.4111Phone
800-480.4111SWIFT/BIC
JPMORGANWire Ref
referencedWire Ref
reflectedRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.